Penn State secures $1M to develop nanotech drug-delivery method

08/14/2012 | MedCityNews.com

Pennsylvania State University received a research grant from the state worth $1 million to further develop a nanotechnology drug-delivery technique for accurate targeting of breast cancer tumors. A research team developed "nanojackets" that use calcium phosphocillate nanoparticles to carry siRNA drugs. Researchers said it will take more than a year to prepare an investigational new drug application.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ